Medical Excellence Capital raises $145m for debut fund

The fund will invest in cell therapy, gene therapy, AI/ML applied to drug discovery, synthetic biology, and regenerative medicine.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this